New clinical study will provide more cancer patients with targeted treatment

24 September, 2025 | Press release

FOCU.SE is a new Swedish study in which genetic analysis of tumours is used to match cancer patients with targeted drugs outside of approved indication. The aim is to give more people access to effective treatment, while gathering valuable knowledge for the future. In...

Long-read genome sequencing: transforming genetic diagnostics for rare diseases

7 May, 2025 | News

Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a perspective article published in Nature Genetics, researchers highlight how long-read whole genome sequencing, LR-WGS, offers a paradigm shift in...

The government provides significant new funding to Genomic Medicine Sweden to strengthen precision medicine

14 April, 2025 | Press release

The Swedish government announces that it will fund Genomic Medicine Sweden (GMS) with SEK 80 million in 2025. The money will go to continued efforts to develop and sustainably implement precision medicine in healthcare in the areas of cancer, rare diseases and...

Sweden contributes to the EU project Beyond One Million Genome plus

19 March, 2025 | News

The comprehensive EU project Beyond One Million Genome plus (B1MGplus) has officially started. The new project, funded by the European Commission under the Digital Europe Programme, coordinates and supports the 1+ Million Genomes’ initiative to enable secure access to...

Cross-border collaboration accelerates diagnosis of rare diseases

28 January, 2025 | News

Living with an undiagnosed disease poses great challenges for both individuals and families. Through initiatives like UDN Sweden and the world’s first Undiagnosed Hackathon for undiagnosed rare diseases, national and international expertise is coming together to...